# Cell-free DNA Methylation for Epithelial Ovarian Cancer

> **NCT04651946** · PHASE2 · UNKNOWN · sponsor: **Lei Li** · enrollment: 400 (estimated)

## Conditions studied

- Epithelial Ovarian Cancer
- DNA Methylation
- Benign Ovarian Tumor
- Training Set
- Validation Set
- Cell-free DNA
- Liquid Biopsy

## Interventions

- **DIAGNOSTIC_TEST:** DNA methylation testing

## Key facts

- **NCT ID:** NCT04651946
- **Lead sponsor:** Lei Li
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-26
- **Primary completion:** 2022-11-26
- **Final completion:** 2022-11-26
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2020-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04651946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04651946, "Cell-free DNA Methylation for Epithelial Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04651946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*